Racial and socioeconomic disparities in parkinsonism

Archives of Neurology

Volumn 68, Issue 4, 2011, Pages 498-503

  Hemming, J Patrick ^a   Gruber Baldini, Ann L ^a   Anderson, Karen E ^a   Fishman, Paul S ^a   Reich, Stephen G ^a   Weiner, William J ^a   Shulman, Lisa M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA; CARBIDOPA PLUS LEVODOPA; DOPAMINE RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT;

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; EDUCATIONAL STATUS; EUROPEAN AMERICAN; FEMALE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PARKINSONISM; PRESCRIPTION; PRIORITY JOURNAL; RACE DIFFERENCE; SOCIAL CLASS; UNIFIED PARKINSON DISEASE RATING SCALE;

AFRICAN AMERICANS; CONTINENTAL POPULATION GROUPS; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEALTH STATUS DISPARITIES; HUMANS; PARKINSONIAN DISORDERS; SOCIOECONOMIC FACTORS;

EID: 79953880778     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2010.326     Document Type: Article

References (33)

1. Marwick C. Healthy People 2010 initiative launched. JAMA. 2000;283(8):989-990.
2. United States Department of Health and Human Services; Agency for Healthcare Research and Quality 2005 national healthcare disparities report: AHRQ publication 06-0017. Agency for Healthcare Research and Quality Web site. http: //www.ahrq.gov/qual/nhdr05/nhdr05.pdf. Accessed October 29, 2010.
3. Schoeni RF, Martin LG, Andreski PM, Freedman VA. Persistent and growing socioeconomic disparities in disability among the elderly: 1982-2002. Am J Public Health. 2005;95(11):2065-2070.
4. Bennett DA, Beckett LA, Murray AM, et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med. 1996;334(2):71-76. (Pubitemid 26017932)
5. Gilman S. Parkinsonian syndromes. Clin Geriatr Med. 2006;22(4):827-842, vi.
6. Albin RL. Parkinson's disease: background, diagnosis, and initial management. Clin Geriatr Med. 2006;22(4):735-751, v.
7. Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson's disease. Lancet Neurol. 2006;5(1):75-86. (Pubitemid 41790698)
8. Cotzias GC, Van Woert MH, Schiffer LM. Aromatic amino acids and modification of parkinsonism. N Engl J Med. 1967;276(7):374-379.
9. Bianchine JR, Shaw GM. Clinical pharmacokinetics of levodopa in Parkinson's disease. Clin Pharmacokinet. 1976;1(5):313-338.
10. Setter SM. Assessing the impact of ease of administration and tolerability on treatment choices in Parkinson's disease. Neurol Clin. 2008;26(3)(suppl):S45-S63, vi.
11. Van Den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003;157(11):1015-1022. (Pubitemid 36628805)
12. Richards M, Chaudhuri KR. Parkinson's disease in populations of African origin: a review. Neuroepidemiology. 1996;15(4):214-221. (Pubitemid 26194305)
13. McInerney-Leo A, Gwinn-Hardy K, Nussbaum RL. Prevalence of Parkinson's disease in populations of African ancestry: a review. J Natl Med Assoc. 2004;96(7):974-979. (Pubitemid 38823513)
14. Pressley JC, Tang M-X, Marder K, Cote LJ, Mayeux R. Disparities in the recording of Parkinson's disease on death certificates. Mov Disord. 2005;20(3):315-321. (Pubitemid 40613292)
15. Duke University Center for the Study of Aging and Human Development. Multidimensional Functional Assessment: The OARS Methodology: A Manual. 2nd ed. Raleigh, NC: Duke University; 1978.
16. Shulman LM, Gruber-Baldini AL, Anderson KE, et al. The evolution of disability in Parkinson disease. Mov Disord. 2008;23(6):790-796.
17. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc. 1968;16(5):622-626.
18. Fahn S, Elton RL; Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease. Vol 2. Florham Park, NJ: Macmillan Health Care Information; 1987:153-164.
19. Cheng EM, Siderowf AD, Swarztrauber K, et al. Disparities of care in veterans with Parkinson's disease. Parkinsonism Relat Disord. 2008;14(1):8-14.
20. Dahodwala N, Xie M, Noll E, Siderowf A, Mandell DS. Treatment disparities in Parkinson's disease. Ann Neurol. 2009;66(2):142-145.
21. Dahodwala N, Siderowf A, Xie M, Noll E, Stern M, Mandell DS. Racial differences in the diagnosis of Parkinson's disease. Mov Disord. 2009;24(8):1200-1205.
22. Yacoubian TA, Howard G, Kissela B, Sands CD, Standaert DG. Racial differences in Parkinson's disease medication use in the reasons for geographic and racial differences in stroke cohort: a cross-sectional study. Neuroepidemiology. 2009;33(4):329-334.
23. Gornick ME, Eggers PW, Reilly TW, et al. Effects of race and income on mortality and use of services among Medicare beneficiaries. N Engl J Med. 1996;335(11):791-799. (Pubitemid 26296540)
24. Quan H, Fong A, De Coster C, et al. Variation in health services utilization among ethnic populations. CMAJ. 2006;174(6):787-791.
25. US Census Bureau. State and County QuickFacts - Baltimore City, Maryland. US Census Bureau Web site. http://quickfacts.census.gov/qfd/states/24/24510 .html. Accessed November 8, 2010.
26. Wilson RS, Schneider JA, Beckett LA, Evans DA, Bennett DA. Progression of gait disorder and rigidity and risk of death in older persons. Neurology. 2002;58 (12):1815-1819. (Pubitemid 34663583)
27. Roberts JS, Connell CM, Cisewski D, Hipps YG, Demissie S, Green RC. Differences between African Americans and whites in their perceptions of Alzheimer disease. Alzheimer Dis Assoc Disord. 2003;17(1):19-26. (Pubitemid 36288242)
28. Goodwin JS, Black SA, Satish S. Aging versus disease: the opinions of older black, Hispanic, and non-Hispanic white Americans about the causes and treatment of common medical conditions. J Am Geriatr Soc. 1999;47(8):973-979. (Pubitemid 29380491)
29. Rybicki BA, Johnson CC, Gorell JM. Demographic differences in referral rates to neurologists of patients with suspected Parkinson's disease: implications for case-control study design. Neuroepidemiology. 1995;14(2):72-81.
30. Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL. Primary care physicians who treat blacks and whites. N Engl J Med. 2004;351(6):575-584. (Pubitemid 39028925)
31. Miller SC, Papandonatos G, Fennell M, Mor V. Facility and county effects on racial differences in nursing home quality indicators. Soc Sci Med. 2006;63(12):3046-3059. (Pubitemid 44648498)
32. Lleras-Muney A. The relationship between education and adult mortality in the US. Rev Econ Stud. 2005;72(1):189-221.
33. Cree B, Waubant E. Does race matter for multiple sclerosis? Neurology. 2010;74 (7):532-533.